In the world of counseling, many clients come to their first session either (a) already taking psychopharmaceutical medications for specific disorders previously diagnosed by a psychiat
I need this completed 01/04/21 by 5pm.
Please no plagiarism and make sure you are able to access all resources on your own before you bid. Main reference comes from Sinacola, R. S., Peters-Strickland, T., & Wyner, J. D. (2020). You need to have scholarly support for any claim of fact or recommendation regarding treatment. Grammar, Writing, and APA Format: I expect you to write professionally, which means APA format, complete sentences, proper paragraphs, and well-organized and well-documented presentation of ideas. Remember to use scholarly research from peer-reviewed articles that are current. Sources such as Wikipedia, Ask.com, PsychCentral, and similar sites are never acceptable. Please remember that resources used must be from peer-reviewed resources such as academic journals. Grammar, Writing, and APA Format: I expect you to write professionally, which means APA format, complete sentences, proper paragraphs, and well-organized and well-documented presentation of ideas. Please follow the example to get full credit for the assignment.
Assignment – Week 6
In the world of counseling, many clients come to their first session either (a) already taking psychopharmaceutical medications for specific disorders previously diagnosed by a psychiatrist or other prescriber, or (b) in need of a psych eval to determine the actual diagnosis and potential psychopharmaceutical options for stabilization. It can be a bit overwhelming when working with clients to know which responses are being influenced by the client's presenting issues and which responses are being influenced by the medications they are on. Creating a medication reference guide is a learning tool that will provide you with a valuable information about the various medications—in a format that makes sense to you—so you are able to navigate psychopharmaceutical medications within the scope of counseling and integrative, collaborative behavioral healthcare.
The goal of this reference guide is for you to create a meaningful, easily accessible reference guide—and relevant project—that produces a tool you will be able to use in your internships as you progress toward licensure. While there is required information that you must find for each medication of the reference guide, feel free to let your learning styles shine through, and use your creative side to organize the information by adding color-coded sections, pictures, diagrams, charts, graphs, website resources, articles, videos, or other elements that you would refer to when a client presents with a specific medication or options for medications. This tool is meant to be a living document that you can add to on an ongoing basis, as you learn new information in the field.
By Day 7
Submit Part 1 of your Psychopharmaceutical Reference Guide with the following categories completed:
- Antidepressants
- Mood Stabilizers
- Anticonvulsants
- Anxiolytics
The template for the PRG lists the required information you will need to enter for each medication. For each category, the template identifies major classes within that category, when applicable. Under each class, you must include at least three commonly prescribed medications within that class. You can include more than three if you would like – remember this is supposed to be a tool you can continue to use as you progress toward licensure.
Required Resources
Document: Psychopharmaceutical Reference Guide Template (Word Document)
Psychopharmaceutical Reference Guide
Student Name Here
Walden University
Table of Contents Exemplar 4 Category: Antidepressants 6 Class: Selective serotonin reuptake inhibitors (SSRIs) 6 Medication 1 6 Medication 2 6 Medication 3 7 Class: Serotonin-norepinephrine reuptake inhibitors (SNRIs) 8 Medication 1 8 Medication 2 9 Medication 3 9 Class: Tricyclic antidepressants (TCAs) 10 Medication 1 10 Medication 2 11 Medication 3 11 Class: Atypical Agents 12 Medication 1 12 Medication 2 13 Medication 3 14 Category: Mood Stabilizers 15 Medication 1 15 Medication 2 15 Medication 3 16 Category: Anticonvulsants (nonbenzodiazepines) 18 Medication 1 18 Medication 2 18 Medication 3 19 Category: Anxiolytics 21 Class: Benzodiazepines 21 Medication 1 21 Medication 2 21 Medication 3 22 Class: Buspirone and others 24 Medication 1 24 Medication 2 24 Medication 3 25 Category: Antipsychotics 27 Class: Antipsychotics – FGA 27 Medication 1 27 Medication 2 27 Medication 3 28 Class: Antipsychotics – SGA 29 Medication 1 29 Medication 2 30 Medication 3 30 Class: Atypical antipsychotics 31 Medication 1 31 Medication 2 32 Medication 3 32 Category: Sleep Aids 34 Class: Sedative hypnotics 34 Medication 1 34 Medication 2 34 Medication 3 35 Class: Z-hypnotics 36 Medication 1 36 Medication 2 37 Medication 3 37 Category: ADHD Medications 39 Class: Stimulants 39 Medication 1 39 Medication 2 39 Medication 3 40 Class: Non-stimulants 41 Medication 1 41 Medication 2 42 Medication 3 42 Category: SUD Medications 44 Buprenorphine 44 Naltrexone 44 Naloxone 45 Methadone 46 Buproprion 46 Acomprosate 47 Topiramate 48 Disulfiram 49
Exemplar
Sample Reference: Xanax
1. Brand Name of Medication |
Xanax, Xanax XR, Niravam |
2. Generic Name of Medication |
Alprazolam |
3. Drug Class |
Benzodiazepines |
4. Manufacturer |
Pfizer, Inc. |
5. Indicated Diagnoses |
Anxiety disorders, panic disorders, anxiety caused by depression |
6. Contraindications |
Narrow-angle glaucoma; if patient is also on itraconazole or ketoconazole; if allergic to Xanax or similar medications (Librium, Klonopin, Tranxene, Valium, Ativan, Serax) |
7. Pregnancy |
Do not use Xanax if pregnant |
8. Potential for Dependency |
Alprazolam may be habit-forming. Misuse of this medication could cause addiction, overdose or death. |
9. Precautions of Use |
· Do not drink alcohol while taking Xanax · Do not take opioid medications while taking Xanax – unless under medical supervision |
10. Allergic Reaction |
Hives, difficulty breathing, swelling of face/lips/tongue/ throat |
11. Common Side Effects |
Common side effects of Xanax include: ataxia, cognitive dysfunction, constipation, difficulty in micturition, drowsiness, dysarthria, fatigue, memory impairment, skin rash, weight gain, weight loss, anxiety, blurred vision, diarrhea, insomnia, decreased libido, increased appetite, slurred speech, and decreased appetite. Other side effects include: hypotension, sexual disorder, muscle twitching, and increased libido. |
12. Concerning Side Effects Needing Medical Attention |
· Depressed mood, thoughts of suicide or hurting self · Racing thoughts, increased energy, unusual risk-taking behavior · Confusion, agitation, hostility, hallucinations · Uncontrolled muscle movements, tremor, seizure, convulsions · Pounding heartbeats or fluttering in chest |
13. Dose Range |
· Treatment for patients with anxiety should be initiated with a dose of 0.25 to 0.5 mg given three times daily. The dose may be increased to achieve a maximum therapeutic effect, at intervals of 3 to 4 days, to a maximum daily dose of 4 mg, given in divided doses. · The successful treatment of many panic disorder patients has required the use of XANAX at doses greater than 4 mg daily. In controlled trials conducted to establish the efficacy of XANAX in panic disorder, doses in the range of 1 to 10 mg daily were used. The mean dosage employed was approximately 5 to 6 mg daily. · Treatment may be initiated with a dose of 0.5 mg three times daily. Depending on the response, the dose may be increased at intervals of 3 to 4 days in increments of no more than 1 mg per day. Slower titration to the dose levels greater than 4 mg/day may be advisable to allow full expression of the pharmacodynamic effect of XANAX. · For patients receiving doses greater than 4 mg/day, periodic reassessment and consideration of dosage reduction is advised. |
14. Types of Administration |
Oral: 0.25 mg, 0.5 mg, 1 mg, 2 mg tablets |
15. Pharmacodynamics |
Clinically, all benzodiazepines cause a dose-related central nervous system depressant activity varying from mild impairment of task performance to hypnosis. it may enhance the activity of GABA (gamma aminobutyric acid), an inhibitory neurotransmitter, in the brain. This produces a hypnosis (a trancelike state) |
16. Half-Life |
A mean half-life of alprazolam of 16.3 hours has been observed in healthy elderly subjects (range: 9.0–26.9 hours, n=16) compared to 11.0 hours (range: 6.3–15.8 hours, n=16) in healthy adult subjects. In patients with alcoholic liver disease the half-life of alprazolam ranged between 5.8 and 65.3 hours (mean: 19.7 hours, n=17) as compared to between 6.3 and 26.9 hours (mean=11.4 hours, n=17) in healthy subjects. In an obese group of subjects, the half-life of alprazolam ranged between 9.9 and 40.4 hours (mean=21.8 hours, n=12) as compared to between 6.3 and 15.8 hours (mean=10.6 hours, n=12) in healthy subjects. |
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
Alprazolam concentrations may be reduced by up to 50% in smokers compared to non-smokers. |
18. Other Notes |
Put your special notes here. For example, Xanax is often prescribed PRN (take as needed). |
19. Source |
Category: Antidepressants
Class: Selective serotonin reuptake inhibitors (SSRIs)
Medication 1
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 2
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 3
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Class: Serotonin-norepinephrine reuptake inhibitors (SNRIs)
Medication 1
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 2
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 3
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Class: Tricyclic antidepressants (TCAs)
Medication 1
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 2
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 3
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Class: Atypical Agents
Medication 1
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 2
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 3
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Category: Mood Stabilizers
Medication 1
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 2
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |
|
18. Other Notes |
|
19. Source |
Medication 3
1. Brand Name of Medication |
|
2. Generic Name of Medication |
|
3. Drug Class |
|
4. Manufacturer |
|
5. Indicated Diagnoses |
|
6. Contraindications |
|
7. Pregnancy |
|
8. Potential for Dependency |
|
9. Precautions of Use |
|
10. Allergic Reaction |
|
11. Common Side Effects |
|
12. Concerning Side Effects Needing Medical Attention |
|
13. Dose Range |
|
14. Types of Administration |
|
15. Pharmacodynamics |
|
16. Half-Life |
|
17. Effects with Poly-Substance Use (e.g., cigarettes, alcohol, etc.) |